Cabometix

Description

Cabometix is ​​intended for the treatment of advanced renal cell carcinoma.

It is also used as monotherapy for the treatment of hepatocellular carcinoma in adult patients, after previous therapy with sorafenib.

Active ingredient: cabozatinib

Prescription drug
A drug from Germany is also available (5,800 euros per package)